Jump To:
- Tuesday, Feb. 9, 2021: Breast Cancer Diagnosis
- Wednesday, Feb. 10, 2021: High Risk Breast Lesions
- Thursday, Feb. 11, 2021: Breast Cancer Therapy
- Friday, Feb. 12, 2021: Breast Cancer Therapy
Tuesday, Feb. 9, 2021: Breast Cancer Diagnosis
Moderator: Shahla Masood, MD
1:00 p.m. – 1:40 p.m.
Clinical Advances in Screening: Digital Breast Tomosynthesis and Automated Breast Ultrasound
Stephen Feig, MD
1:40 p.m. – 2:20 p.m.
Localization of Non-Palpable Breast Lesions
Laurie Margolies, MD
2:20 p.m. – 3:00 p.m.
Diagnostic Challenges in Interpretation of Breast Core Needle Biopsy
Shahla Masood, MD
3:00 p.m. – 3:15 p.m.
BREAK
3:15 p.m. – 3:55 p.m.
Breast Imaging of Young, Pregnant or Lactating Women
Laurie Margolies, MD
3:55 p.m. – 4:35 p.m.
Pregnancy Associated Breast Cancer
Heather Macdonald, MD
4:35 p.m. – 5:15 p.m.
Imaging of High Risk Lesions
Gary J. Whitman, MD
Wednesday, Feb. 10, 2021: High Risk Breast Lesions
Moderator: Karen Daily, DO
1:00 p.m. – 1:40 p.m.
Current Understanding of the Biology of Ductal Carcinoma in situ
Steven Narod, MD
1:40 p.m. – 2:20 p.m.
Clinical Significance Ductal Carcinoma in situ: A Radiologists Perspective
Stephen Feig, MD
2:20 p.m. – 3:00 p.m.
Treatment Implications of Germline BRCA Mutations in Patients with Breast Cancer
Banu Arun, MD
3:00 p.m. – 3:15 p.m.
BREAK
3:15 p.m. – 3:55 p.m.
Surgical Management of High Risk Breast Cancer Patients
Freya Schnabel, MD
3:55 p.m. – 4:35 p.m.
Management of non-BRCA1,2 Mutation Carriers
Judy Garber, MD
4:35 p.m. – 5:15 p.m.
The Care of the Hereditary Breast and Ovarian Cancer Patient beyond Chemoprevention and Surgery
Heather Macdonald, MD
Thursday, Feb. 11, 2021: Breast Cancer Therapy
Moderator: Lisa Spiguel, MD
1:00 p.m. – 1:40 p.m.
Surgical Management of the Axilla after Neoadjuvant Treatment
Armando E. Giuliano, MD
1:40 p.m. – 2:20 p.m.
Current Update and Outcome in Immediate Axillary Lymphatico Venous Anastomosis Post Axillary Lymph Node Dissection
Risal Djohan, MD
2:20 p.m. – 3:00 p.m.
Hypofractionted Post Mastectomy Radiation
Bruce Haffty, MD
3:00 p.m. – 3:15 p.m.
BREAK
3:15 p.m. – 3:55 p.m.
Current Status of Proton Therapy in Breast Cancer
Nancy P. Mendenhall, MD
3:55 p.m. – 4:35 p.m.
Carcinomas Arising in the Nipple: What Patients Choosing Nipple Sparing Mastectomy Should Know
Susan Lester, MD, PhD
4:35 p.m. – 5:15 p.m.
Impact of Affect Reactivity and Regulation on Breast Cancer Treatment Decisions
David Spiegel, MD
Friday, Feb. 12, 2021: Breast Cancer Therapy
Moderator: Coy Heldermon, MD, PhD
1:00 p.m. – 1:40 p.m.
The Evolution of Extreme Oncoplasty
Melvin J. Silverstein, MD
1:40 p.m. – 2:20 p.m.
Nerve Sparing Mastectomy for Improved Sensory Recovery in Breast Reconstruction
Risal Djohan, MD
2:20 p.m. – 3:00 p.m.
Triple Negative Breast Cancer: From Classification to Treatment Decision Making
Jorge S. Reis-Filho, MD, PhD
3:00 p.m. – 3:15 p.m.
BREAK
3:15 p.m. – 3:55 p.m.
Systemic Therapy for Early Stage Breast Cancer
Julie R. Gralow, MD
3:55 p.m. – 4:35 p.m.
Personalizing Systemic Therapy for Advanced Breast Cancer
Debu Tripathy, MD
4:35 p.m. – 5:15 p.m.
Update on Neoadjuvant Chemotherapy
Terry P Mamounas, MD